BIOMAT Database Logo BIOMAT Database Logo

[Experimental studies of the combination of vincristine and 1,2:5,6-dianhydrogalactitol]. 1987

Y J Fan, and R Han, and J Zhou, and M Li

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D003961 Dianhydrogalactitol One of the cytotoxic dihalohexitols that alkylates and cross-links DNA via an epoxide group during all phases of the cell cycle, resulting in a disruption of DNA function and cell cycle arrest. It has antineoplastic activity and also causes bone marrow toxicity. Dianhydrodulcitol,Diepoxydulcitol,Diepoxygalactitol,1,2,5,6-Dianhydrogalactitol,1,2-5,6-Dianhydrogalactitol,NSC-132313,NSC 132313,NSC132313
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014750 Vincristine An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.) Leurocristine,Citomid,Farmistin,Oncovin,Oncovine,Onkocristin,Vincasar,Vincasar PFS,Vincristin Bristol,Vincristin medac,Vincristine Sulfate,Vincrisul,Vintec,cellcristin,PFS, Vincasar,Sulfate, Vincristine
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Y J Fan, and R Han, and J Zhou, and M Li
[Use of 1,2:5,6-dianhydrogalactitol in combination with maytansine in experimental tumor therapy].
September 1983, Yao xue xue bao = Acta pharmaceutica Sinica,
Y J Fan, and R Han, and J Zhou, and M Li
1,2:5,6-Dianhydrogalactitol in advanced breast cancer.
May 1978, Cancer treatment reports,
Y J Fan, and R Han, and J Zhou, and M Li
Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313).
October 1972, Cancer chemotherapy reports,
Y J Fan, and R Han, and J Zhou, and M Li
Alkylation by 1,2:5,6-dianhydrogalactitol of deoxyribonucleic acid and guanosine.
March 1980, The Biochemical journal,
Y J Fan, and R Han, and J Zhou, and M Li
Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivo.
July 1982, Cancer research,
Y J Fan, and R Han, and J Zhou, and M Li
Gas-chromatographic analysis for 1,2:5,6-dianhydrogalactitol, an anti-neoplastic agent, in plasma.
October 1976, Clinical chemistry,
Y J Fan, and R Han, and J Zhou, and M Li
Dominance of resistance to the alkylating agent 1,2:5,6-dianhydrogalactitol in P388 mouse lymphoma hybrid cells.
January 1989, Cancer chemotherapy and pharmacology,
Y J Fan, and R Han, and J Zhou, and M Li
Phase I study of a five-day intermittent schedule for 1,2:5,6-dianhydrogalactitol (NSC-132313).
January 1976, Journal of the National Cancer Institute,
Y J Fan, and R Han, and J Zhou, and M Li
[Effect of 1,2:5,6-dianhydrogalactitol and 1,2:5,6-dianhydro-3,4-diacetylgalactitol on DNA synthesis in the cells of melanoma B16, bone marrow, small intestine epithelium, spleen and liver of mice].
September 1984, Biulleten' eksperimental'noi biologii i meditsiny,
Y J Fan, and R Han, and J Zhou, and M Li
[Effects of 1,2:5,6-dianhydrogalactitol on the bone marrow stem cells in normal and melanoma-bearing mice (author's transl)].
December 1980, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Copied contents to your clipboard!